I am an immunologist, and business developer who thrives on building alliances to drive drug discovery and development strategy. With experiences in both the United States (US) and Europe (EU) I seek to strengthen cross-cultural bridges.

I moved from India to the US for my PhD at Purdue University from an outstanding lab studying tyrosine kinases in the adaptive immune cell system. As a post-doctoral scientist, my work done in both the US and the EU developed cutting-edge technologies for imaging and genomic analysis of the T-lymphocytes.

As a scientist at oncology start-ups in Boston I led research, managed teams, and formed alliances enabling development of a novel tumor-targeting peptide (chlorotoxin) and a stapled peptide (Sulanemadlin) to IND submission.

At Third Rock Ventures, I organized cross-portfolio scientific forums, meeting members of the start-up, CRO, and VC communities to implement efficiencies for newco formation and success.

At the discovery arm of Champions Oncology (Corellia.AI), I led discussions with partners on both funding and co-development of assets.

With my current role at Evotec, I took the opportunity to move back to the EU and develop new business in BeNeLux by building relationships with leaders across the territory. It has been a fruitful journey.

My experience spans the breadth of two continents ranging from academia, start-ups newcos, biotechnology companies, VC, and contract research organizations focusing on strategic partnering.